Surrogacy process

Is IVF suitable for older women in China? This article analyzes eligibility criteria, success factors, complete process, and timeline from a reproductive medicine perspective. Covers key indicators like AMH and FSH, age-related differences, and real-world consultation tips to help older individuals make informed decisions.

The egg retrieval phase of IVF in China typically takes 12-14 days, including ovarian stimulation and the retrieval procedure. This article explains the complete process, daily schedule, key details, and management of different scenarios from a reproductive doctor's perspective.

Are there discounts for multiple IVF cycles in China? Public hospitals charge strictly per procedure with no discounts, while private hospitals may offer packages or cycle discounts. Understand the fee structures, cost components, and potential risks of different institutions to avoid falling into 'success package' traps.

Ways to pursue rights in IVF in China include hospital complaints, health commission complaints, medical dispute mediation, legal proceedings, and more. This article details the rights protection processes, required materials, and precautions for different types of disputes, helping patients rationally protect their rights.

Egg freezing costs in China vary by city, hospital, and individual ovarian response. A single cycle typically costs 20,000-50,000 RMB, including examinations, ovulation induction, egg retrieval surgery, and freezing fees. Reproductive doctors analyze cost breakdowns, age differences, and hidden costs to help you make informed decisions.

Can out-of-town patients get medical insurance reimbursement for IVF in China? This article provides a detailed explanation of the national assisted reproduction medical insurance policies, covering the cross-provincial medical treatment filing process, reimbursable items, reimbursement ratios, and restrictions. It helps out-of-town patients understand the application methods and precautions for IVF cost reimbursement, allowing for a well-planned medical journey.

Third-generation IVF PGT technology is a genetic testing method for embryo chromosomal abnormalities and monogenic diseases. This article analyzes the indications, process, success rates, and risks of PGT-A/PGT-M/PGT-SR from a reproductive medicine perspective, helping families with genetic risks objectively understand this technology.

China's IVF medical insurance reimbursement has been piloted in Beijing, Guangxi, Inner Mongolia, Gansu, etc., covering egg retrieval, embryo culture, transfer, freezing, and other items. Conditions include local insurance, designated hospital treatment, and items within the catalog. The reimbursement rate is about 50%–70% with an annual limit. This article details the conditions, materials, process, and precautions.

PGT-SR is a preimplantation genetic testing technique specifically for chromosomal structural rearrangements, suitable for carriers of balanced translocations, Robertsonian translocations, inversions, etc. This article provides a detailed analysis of PGT-SR indications, contraindications, complete process, timing, cost factors, and key clinical decision points from a reproductive physician's perspective.

IUI technology in China is well-established, with a single-cycle clinical pregnancy rate of approximately 10%-20%, influenced by factors such as female age, ovarian function, sperm quality, and tubal status. This article systematically analyzes the IUI procedure, cycle timeline, suitable candidates, cost structure, and key considerations from a reproductive medicine perspective, helping patients build scientific understanding and reasonable expectations.

Sperm freezing technology in China has been maturely applied in clinical practice for over 30 years, with vitrification recovery rates exceeding 90%. Clinical pregnancy rates using frozen sperm for ICSI show no significant difference from fresh sperm. This article analyzes the technical principles, complete procedures, suitable candidates, potential risks, and common misconceptions from a reproductive medicine perspective, helping patients scientifically assess whether sperm freezing is appropriate for their situation.

China donor sperm IVF is suitable for non-obstructive azoospermia, severe oligoasthenoteratozoospermia, and genetic diseases. The process includes sperm bank application, matching, and IVF cycle. Medical indications, legal identity, and psychological readiness are required. This article, compiled by a reproductive doctor, covers the full donor sperm IVF process, application conditions, timeline, and common questions.

In China, IVF from initial consultation to pregnancy test typically takes 2-4 months. The exact duration depends on the protocol, age, hospital procedures, and whether frozen embryos or genetic testing is involved. This article breaks down the timeline for each stage, including pre-treatment checks, ovarian stimulation, egg retrieval, embryo culture, transfer, and luteal support, helping patients plan their treatment scientifically.

When both partners have fertility issues, how is IVF treatment conducted in China? This article provides a comprehensive analysis from dual-factor infertility evaluation, protocol planning, cycle process to precautions, helping patients clearly understand the treatment path and preparation points.

Egg donation technology in China primarily involves the donor egg IVF process, applicable to women with ovarian failure, genetic disease carriers, and other conditions. Donors must meet medical standards such as age and health, while recipients need to register and wait at hospitals, with waiting times varying by region and center. This article analyzes the medical procedures, legal boundaries, and practical details of domestic egg donation.

In China, one IVF cycle typically involves one fresh embryo transfer; if the fresh transfer is cancelled, subsequent frozen embryo transfers are considered new cycles. The exact number depends on embryo quality, endometrial conditions, and physician assessment. This article provides a detailed clinical explanation of transfer frequency and related considerations.

China IVF legal consultation services are real. Formal reproductive centers usually have legal advisors or cooperate with law firms. This article provides detailed answers to legal issues related to IVF, including embryo disposition, informed consent, medical disputes, and embryo ownership in divorce, helping patients understand their rights and consultation channels.

ERT (Endometrial Receptivity Test) is clinically applied in China for patients with recurrent implantation failure. This article provides an objective analysis of the technical principles, domestic application status, testing process, suitable populations, and limitations, helping patients understand the practical value of ERT in assisted reproduction.

Is IVF effective for immune infertility? This article provides a detailed analysis from a reproductive doctor's perspective, covering examination items, IVF procedures, suitable candidates, precautions, and factors affecting success rates, helping patients fully understand the real path from diagnosis to treatment.

There is no universal standard for how many IVF cycles are considered normal. Clinical data shows about 60% of patients achieve pregnancy within 3 cycles. Success rates are influenced by age, embryo quality, endometrial receptivity, and other factors. This article analyzes the relationship between cycle number and success rate from a reproductive medicine perspective, helping patients set realistic expectations.